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Abstract
Cyanobacteria can produce groups of structurally and functionally unrelated but highly potent
toxins. Cyanotoxins are used in multiple research endeavours, either for direct investigation of
their toxicologic properties, or as functional analogues for various biochemical and physiological
processes. This paper presents occupational safety guidelines and recommendations for personnel
working in field, laboratory or industrial settings to produce and use purified cyanotoxins and toxic
cyanobacteria, from bulk harvesting of bloom material, mass culture of laboratory isolates, through
routine extraction, isolation and purification. Oral, inhalational, dermal and parenteral routes are
all potential occupational exposure pathways during the various stages of cyanotoxin production
and application. Investigation of toxicologic or pharmacologic properties using in vivo models may
present specific risks if radiolabelled cyanotoxins are employed, and the potential for occupational
exposure via the dermal route is heightened with the use of organic solvents as vehicles. Inter- and
intra-national transport of living cyanobacteria for research purposes risks establishing feral
microalgal populations, so disinfection of culture equipment and destruction of cells by autoclaving,
incineration and/or chlorination is recommended in order to prevent viable cyanobacteria from
escaping research or production facilities.
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Introduction
Over 40 species in some 20 cyanobacterial genera can pro-
duce a range of structurally and functionally diverse tox-
ins, known as cyanotoxins. Freshwater and marine
cyanobacteria, encompassing both planktonic and ben-
thic forms, can produce potent toxins, some of which
have been well characterised in terms of their toxic effects
and some of which are less well-understood [1]. The
known cyanotoxins can exert their toxic effects through a
variety of mechanisms (depending on the particular
toxin): some are potent neurotoxins that can cause respi-
ratory dysfunction and death through paralysis of respira-
tory muscles, e.g. saxitoxins, anatoxin-a, anatoxin-a(S).
Some affect the liver and other organs, e.g. microcystins,
nodularin, cylindrospermopsin, and some exert acute irri-
tant effects on the skin and mucous membranes, e.g.
debromoaplysiatoxin, lyngbyatoxin A. Some cyanotoxins
are potent tumour promoters, e.g. debromoaplysiatoxin,
lyngbyatoxin A, microcystins, nodularin. Long-term, low-
dose exposures to microcystins and/or cylindrosper-
mopsin in drinking water are suspected (but so far
unproven) risk factors for the development of some types
of cancer. Cyanobacteria are rich sources of novel bioac-
tive compounds, many of which are poorly researched
with respect to toxicity [2].
Several cyanotoxins have been chemically synthesised,
e.g. anatoxin-a [3-5], cylindrospermopsins [6,7], saxitox-
ins [8,9], lyngbyatoxin A [10,11], aplysiatoxins [12], and
one of the microcystins and some microcystin structural
components [13,14]. However, the processes involved in
synthesis of cyanotoxins like cylindrospermopsin and
microcystins are complex and multiple steps are required,
so those particular molecules are unlikely to be synthe-
sised on a commercial scale in the near future. Therefore
the most efficient methods for obtaining research-ena-
bling quantities of many cyanotoxins in the short to
medium turn will be to bulk-harvest cyanobacteria from
natural waterbodies or to grow laboratory isolates in mass
culture. Figure 1 shows field collection of bloom biomass
for the purpose of extracting cyanotoxins (nodularin from
Nodularia spumigena in this example). Although blooms
such as in Figure 1 may attain very high densities, such
conditions are not frequently encountered by staff
engaged in field sampling for water quality monitoring
purposes. Laboratory cultures grown for toxin production
are likely to contain higher concentrations of specific tox-
ins than are usually found in the field. Regular occupa-
tional handling of mass culture material would therefore
be expected to present a greater human health risk should
accidental exposures occur.
The hazard assessment guidelines presented in this man-
uscript are designed for use by scientific and technical staff
involved in any of the various stages necessary to concen-
trate toxic cyanobacteria for the isolation of known cyan-
otoxins or natural products of unknown or uncertain
toxicity, and subsequent extraction, isolation and purifi-
cation of cyanotoxins for sale or for their own research
programs. Exposure routes for actual and potential harm-
ful effects are by inhalation, cutaneous contact, and oral
or parenteral exposure. Toxic concentrations and doses
will vary significantly depending on the particular cyano-
toxin being processed and the exposure route, as will the
expected health effects. In the absence of specific risk
assessment guidelines for handling individual cyanotox-
ins, these recommendations should be regarded as pre-
liminary and intentionally non-specific. This hazard
assessment will present a precautionary approach for
research and technical staff working to extract, isolate,
concentrate and purify cyanobacterial toxins for research
purposes. This document is not intended for use by work-
ers exposed to cyanobacteria in other occupational set-
tings such as sample collection of water or associated
biota, or disposal of nuisance biomass; separate occupa-
tional health and safety guidelines are appropriate for
such activities, e.g. see Metcalf et al [15] for environmental
sampling protocols.
Bulk harvesting of cyanobacteria: collection 
from natural waterbodies or laboratory mass 
culture
Oral exposure risks
Harvesting of dense cyanobacterial biomass may result in
higher short-term exposures than would be experienced
during recreational activities. Most leisure-seekers avoid
Field collection of bloom material for cyanotoxin extraction Figure 1
Field collection of bloom material for cyanotoxin 
extraction. Unobtrusive and common-sense personal pro-
tective equipment - waterproof boots and gloves in this case 
- may be used to harvest bloom biomass. Workers undertak-
ing such activities should be familiar with the risks of acciden-
tal immersion, however, and care must be taken to ensure a 
secure footing. Photo by author WAW.Environmental Health 2009, 8:52 http://www.ehjournal.net/content/8/1/52
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exposure to dense surface scums of planktonic cyanobac-
teria and floating mats of liberated benthic cyanobacteria,
whereas such infestations will be the focus of attention for
scientific staff. It follows that when collecting bloom bio-
mass, the utmost care should be taken to avoid accidental
immersion, as oral ingestion of contaminated water may
occur by reflex swallowing. The associated risks are under-
lined by a well-documented case report concerning an
individual who was planning to swim at a lake in Sas-
katchewan, Canada that was affected by a cyanobacteria
bloom. He accidentally fell into the water, and swallowed
an estimated half-pint (240 mL); within hours he devel-
oped an acute gastro-intestinal disorder which progressed
to a flu-like illness characterised by fever, severe headache,
arthralgia and myalgia [16]. It should be noted that sud-
den immersion stimulates reflex swallowing by the so-
called immersion-deglutition reflex; the swallowing reflex
may be more likely to occur following immersion in water
with temperatures below 25°C [17,18]. Sudden acciden-
tal immersion in cold waters compared to warmer waters
in temperate or tropical regions may present a relatively
greater risk of reflex swallowing. However, occupational
safety programs covering bulk harvesting of toxic or
potentially toxic cyanobacteria should encompass meas-
ures to minimise the risk of accidental immersion at all
latitudes.
Workers collecting cyanobacterial biomass by boat consti-
tute a special case. Staff should therefore pay particular
attention to prevention of accidental immersion and the
subsequent potential for inadvertent oral exposure.
Appropriate considerations are awareness of weather con-
ditions, seaworthiness of the vessel, basic water confi-
dence and swimming proficiency, wearing of lifejackets by
all staff, provision of water resistant cell phones, and use
of safety rails or harnesses. Biomass should be gathered
with buckets or nets that are tethered to the boat so that
workers can avoid leaning over the side of their boat - a
dangerous activity in this regard. At least two workers
should be deployed for any bloom harvesting excursion,
with one staffer at all times not directly exposed to scum
material and thus available to summon and provide
assistance should it be required.
Cutaneous exposure risks
Most of the known cyanotoxins are highly water soluble,
so the risk of intoxication via the dermal route for workers
handling cyanobacteria in waterbodies or growing labora-
tory cultures would appear to be negligible. As discussed
below, this may not be the case during preparation of
purified cyanotoxins if solvents that could increase skin
permeability are used, e.g. dimethyl sulfoxide. However,
some cyanotoxins, particularly the dermal irritant toxins -
aplysiatoxin, debromoaplysiatoxin and the lyngbyatoxins
- produced by some marine cyanobacteria (mainly Lyng-
bya majuscula) [19] represent an occupational risk of acute
skin irritant effects. In addition, the highly water soluble
toxin cylindrospermopsin, produced by several freshwater
and brackish water cyanobacterial genera, has been
shown to produce cutaneous irritant and delayed-contact
hypersensitivity reactions in experimental animals
exposed to high concentrations [20], and cylindrosper-
mopsin-producing cyanobacteria have produced delayed-
contact hypersensitivity reactions in a human volunteer
study [21]. The skin sensitising potential of cyanobacteria
is poorly understood and under-researched, but there are
some convincing case reports of allergic reactions pro-
voked by cutaneous exposure to freshwater cyanobacteria,
and numerous anecdotal reports of acute skin eruptions
following such contact [22]. While the incidence and
prevalence of cyanobacteria-related hypersensitivity reac-
tions are unknown, as a precautionary measure the use of
waterproof gloves is recommended for all staff handling
bulk cyanobacterial biomass. Workers who are extracting,
processing and working with purified cyanotoxins are
advised to wear skin protection because of the (albeit
poorly understood and unquantified) potential for sensi-
tisation.
Inhalational exposure risks
The potential for deleterious health effects from inhala-
tion of cyanobacteria and cyanobacterial products in field
locations - marine and inland waters - is not well under-
stood. Some workers [23-26] have suggested that inhala-
tional exposure to toxic cyanobacterial products may have
contributed to the acute illnesses, some severe, in two
groups of British soldiers and sea cadets in 1989 [27] and
1996 [24]. The recruits were participating in canoeing
exercises involving full immersion in cyanobacteria-
affected waterbodies. However, assuming the reported ill-
nesses (fever, malaise, sore throat, unproductive cough,
diarrhoea, vomiting, abdominal pain, headache, pneu-
monia) were caused by exposure to toxic cyanobacteria,
the signs and symptoms may have developed as a result of
oral exposure to cyanotoxins. Ingestion of water was
reported in both these incidents, which involved canoe
capsizing trials [24,27]. The possibility of reflex swallow-
ing associated with sudden immersion leading to expo-
sure to toxic cyanobacteria by the oral route should be
considered when reviewing those events.
A prospective epidemiological study of recreational expo-
sure to cyanobacteria found a statistically significant
increase in reporting of respiratory symptoms amongst
study subjects exposed to recreational waters with high
cyanobacteria biomass estimates when compared to those
exposed to waters with low cyanobacteria levels [28].
However, respiratory symptoms were mostly mild in
extent, and the study was not designed to link the reported
incidence of symptoms with specific exposure routes.Environmental Health 2009, 8:52 http://www.ehjournal.net/content/8/1/52
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Two recent prospective studies of recreational exposure to
cyanobacteria were designed to examine inhalational
exposure: study subjects wore personal air samplers, and
high-volume air samplers were employed at study sites in
order to estimate airborne microcystin (MC) exposures.
Low concentrations of MCs were detected by these meth-
ods. Low microcystin concentrations were also detected in
post-exposure nasal swabs taken from subjects in one
study, though no MCs were found in blood samples [29].
No differences in symptom reporting between study and
control subjects were identified in either study [29,30].
Experimental work with rodent models has shown that
some purified cyanotoxins can efficiently gain access to
the circulation via the bronchial tract [31,32], but such
studies involved direct application of solubilised cyanoto-
xins to the nasal or tracheal mucosa, i.e. these were not
inhalational exposure experiments. A study by Benson et
al [33] of inhalational exposure over seven days in mice to
microcystin-LR (MC-LR) did not demonstrate any adverse
pathological effects on the liver, kidney or gastrointestinal
tract that would be expected after parenteral exposure.
Inflammatory and necrotic damage to the nasal epithe-
lium was the sole pathological finding [33]. The authors
estimated daily exposures of 50 μg/kg body weight in their
mice exposed to the highest experimental concentrations,
which is the commonly accepted mouse acute LD50 by the
intraperitoneal route [34]. A conference abstract [35]
reported lethal exposures to MC-LR aerosol in mice by a
single 10 minute inhalation dose. The LC50 was calculated
at 18 μg/L of air, which, for a 25 g mouse with a minute
ventilation of 40 mL would equate to an exposed dose of
290 μg/kg. These findings support general toxicological
principles with respect to exposure routes for water solu-
ble toxins and the efficiency with which each route pro-
vides access to the circulation: parenteral
exposures>inhalational>oral>dermal.
While the inhalational route for exposure to cyanotoxins
may be hazardous in theory, and the limited experimental
evidence may support such concerns, the implications for
exposure to toxigenic doses of cyanotoxins in field settings
depend also on the degree to which intracellular cyanoto-
xins or those found freely soluble in the water are able to
be effectively aerosolised. Cyanotoxins can be aerosolised;
experimental studies on microcystins have shown that a
bubble-bursting mechanism that models wind-generated
wave action can transfer the toxin into air [36]. However,
translating this experimental finding into implications for
field exposure is problematic and requires more research.
We are not aware of compelling evidence, anecdotal or
otherwise, that cyanotoxins present in wet sprays gener-
ated by wave action or powered water craft have caused
intoxication via inhalation in humans, wild animals or
livestock in freshwater systems.
There are a small number of intriguing, largely anecdotal
reports of outbreaks of respiratory illness associated with
(presumed) inhalation of cyanobacterial products that
have contaminated reticulated supplies and have aero-
solised in hot water, as well as some preliminary epidemi-
ological investigations into cyanobacteria in saunas
[22,37]. The relationship to contaminating cyanobacteria
in these incidents is tenuous, and considerably more
research investigations are needed in order to ascertain the
risks from cyanotoxins atomised in hot water. These
reports presumably also bear little relevance when consid-
ering occupational exposures in open waterbodies.
Some toxic marine cyanobacteria may present a different
picture with respect to inhalational exposure risks. We dis-
cuss some related issues below, though again the whole
topic of aerosolised cyanotoxins is poorly understood.
Toxic Lyngbya majuscula in coastal waters may represent a
rather specific hazard, as there are several anecdotal
reports and outbreak-initiated investigations of non-bath-
ers at beachside locations suffering respiratory and ocular
symptoms that were temporally related to the presence of
L. majuscula blooms [19]. An outbreak of upper respira-
tory and eye symptoms occurred amongst small business
employees and visitors at a waterfront precinct in Hawaii
in 1983. While not definitively confirmed, the causative
agent was thought to be aerosolised products of a L.
majuscula bloom that coincided with high tides and big
surf generated by a tropical storm [38].
A cursory mention of occupational respiratory symptoms
associated with harvesting Trichodesmium  biomass by
plankton net is made in a report discussing suspected
toxic properties of this pelagic marine cyanobacterium.
The report does not discuss prevailing weather and wave
conditions when their Trichodesmium (predominantly T.
thiebautii, with some T. erythraeum) was collected, so it is
difficult to assess the degree to which filaments may have
been aerosolised [39]. The toxicity of pelagic marine
cyanobacteria (i.e. planktonic open-ocean species, as dis-
tinct from benthic coastal zone forms) is a poorly-under-
stood and under-researched topic, though there are
growing suspicions that several planktonic forms are
capable of producing toxins. A paper from Brazil in 1963
discussed earlier reports of mass outbreaks of a febrile res-
piratory illness attributed to onshore blooms of Trichode-
smium  [40]. However, we are not convinced that this
disease, named "Tamandaré Fever", might not have been
equally explained by exposure to unidentified or mis-
identified toxic blooms of the marine dinoflagellate Kare-
nia brevis. Brevetoxins, the cyclic polyether toxins pro-
duced by K. brevis, are capable of being aerosolised to
irritant and sensitising concentrations and can cause acute
respiratory symptoms in beach workers and visitorsEnvironmental Health 2009, 8:52 http://www.ehjournal.net/content/8/1/52
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[41,42]. For a recent review of the toxicity of marine
cyanobacteria and discussion of Tamandaré Fever, see
Stewart & Falconer [2].
Because of the lack of evidence for harmful effects via
inhalation from harvesting cyanobacterial biomass from
marine or fresh waters, we do not currently recommend
the use of protective respiratory apparatus for such work.
These recommendations should, however, be subject to
revision if and when plausible reports of hazardous field
conditions are published. We suggest that wherever possi-
ble such tasks should be scheduled at locations and in
weather conditions that minimise spray generation, i.e.
on calm waters undisturbed by powered watercraft. Har-
vesting should only take place when prevailing wind,
wave and tidal conditions are such that spray generation
is minimised. Such conditions are necessary requirements
for harvesting surface scums of planktonic cyanobacteria
that would otherwise be dispersed in choppy waters. Har-
vesting littoral zone benthic cyanobacteria such as L.
majuscula from beaches or rock ledges in strong surf con-
ditions is fundamentally unsafe in any case, due to the risk
of imbalance and potentially catastrophic immersion.
Workers harvesting bulk cyanobacterial biomass need to
be particularly cautious when dealing with senescent
bloom material that may be subject to anaerobic decom-
position, because of the potential for liberation of hazard-
ous concentrations of hydrogen sulfide. A recent incident
in France highlighted the potential for misadventure here;
an extensive overgrowth of Ulva lactuca (sea lettuce, an
otherwise non-toxic and indeed edible chlorophyte mac-
roalga) reportedly resulted in the death of a horse and its
rider being rendered unconscious after being overcome by
H2S. Concern was also raised that the sudden death of a
truck driver working to remove rotting biomass may also
have been related to H2S intoxication, but this was appar-
ently unconfirmed at the time [43].
Harvesting and handling dry cyanobacterial biomass
The previous discussion and recommendations relate to
the collection of wet cyanobacterial biomass, i.e. harvest-
ing aquatic or marine toxic cyanobacteria directly from
the environments in which they grow. The potential for
inhaling harmful amounts of cyanobacterial products in
field conditions increases where desiccated cyanobacterial
biomass is harvested from shorelines and beaches, and
occupational health and safety recommendations should
be revised accordingly. Collecting such material may una-
voidably generate dust which poses an inhalation hazard.
Harvesting dry Lyngbya majuscula from beaches provides a
case in point. Lyngbya-related toxins may be expected to
cause acute respiratory symptoms if sufficient quantities
of toxic dust are inhaled. Local authorities in south-east
Queensland, where severe L. majuscula blooms occur reg-
ularly in coastal waters and embayments, mandate the use
of protective respiratory apparatus for their staff that are
responsible for the collection and disposal of cyanobacte-
rial biomass that has washed up on beaches [44]. Dry
toxic L. majuscula should be considered a particular haz-
ard, though we suggest that prudent precautionary princi-
ples dictate that for all cyanobacteria, harvesting wet
cyanobacterial biomass should, wherever possible, be
favoured over collection of dry material. Light wetting of
the required amount of desiccated material with a water-
ing-can prior to collection may be all that is required to
prevent dust being liberated; if collection of dry biomass
is considered necessary, we recommend the use of respira-
tor masks.
Mass culture of toxic cyanobacteria in the laboratory
Many scientists procure sufficient quantities of cyanotox-
ins for their research by growing cyanobacterial isolates in
their laboratory. Cyanobacteria are grown using inorganic
media and various techniques can be employed depend-
ing on the amount of toxin required and the available
facilities. Simple methods may involve batch culture in a
5 or 10 litre flask using ambient light and temperature and
intermittent aeration, which should allow for production
of microgram to milligram quantities of cyanotoxins.
More efficient systems may feature a dedicated growth
chamber to allow temperature and illumination to be
controlled; continuous culture vessels may be aerated and
supplemented with additional CO2. Large-scale systems
may have capacities of over 1,000 litres. When volumes of
this size are being grown extra caution needs to be exer-
cised in order to contain any spills and to prevent aerosols
from being generated. Vented air from cultures should be
passed over an acidified hypochlorite solution to inacti-
vate any cells and cyanotoxins. Figure 2 shows a mass cul-
ture of toxigenic cyanobacteria in operation.
Occupational safety guidelines for laboratory production
of toxigenic cyanobacteria should focus on avoiding con-
tact with skin and mucous membranes. Gloves should be
worn when handling culture vessels and equipment, and
eye protection should be considered for procedures that
may involve splash generation, e.g. when cleaning equip-
ment or pouring out vessel products. As laboratory mass
culture of cyanobacteria is conducted in closed systems,
oral and inhalational exposures are not considered haz-
ardous for such work, provided routine microbiological
procedures are used when pipetting inoculum and vented
air is contained and decontaminated. Aeration should be
turned off five minutes before opening culture vessels so
that aerosols can settle.
Contingency protocols should be established to deal with
spills; disrupted integrity of a large-scale culture system
could potentially result in the release of large volumes ofEnvironmental Health 2009, 8:52 http://www.ehjournal.net/content/8/1/52
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toxic material, so design features to minimise the likeli-
hood of spillage such as isolation valves and secondary
containment may be pertinent. Every attempt should be
made to recover spillage and, if possible, extract usable
concentrations of cyanotoxin. In the recovery process, aer-
osols may be generated if high-capacity pumps are used to
transfer bulk culture material from the floor to the open
top of a temporary or repaired containment vessel. Fol-
lowing cleanup of liquid spills the affected area should be
decontaminated with hypochlorite (5-10% v/v).
Culture vessels should be identified as containers for toxic
liquids by tagging with biohazard labels. Information on
the species being grown, toxin/s produced, and the loca-
tion of specific protocols for managing accidental release
should be clearly visible.
Concentration, lyophilisation and shredding/
powdering
Wild-harvested or laboratory cultured cyanobacteria will
usually be concentrated and/or lyophilised for storage
and subsequent solvent extraction. Concentration of
planktonic cyanobacteria can be accomplished by either
filtration or centrifugation. Both procedures will require
skin protection (lab coat, nitrile or latex gloves) and safety
glasses to prevent eye splash. Disposal of filtrates, super-
natants and used culture media should be undertaken
with consideration given to the prevention of environ-
mental contamination by viable cyanobacterial cells (see
below).
Lyophilisation of planktonic and benthic cyanobacteria
may create an additional hazard potential for exposure by
inhalation. Therefore subsequent processing of dry mate-
rial will require precautions to minimise such exposures
because of the potential risk of respiratory irritation (par-
ticularly from the Lyngbya-related toxins) and/or sensitisa-
tion. In the laboratory, this can be achieved by performing
tasks involving lyophilised or naturally desiccated cyano-
bacteria in a fume cupboard. Small quantities may be
shredded with a simple device such as a domestic coffee
grinder; a swing mill is useful for larger amounts or to
achieve a fine powder. Either way, transfer of ground
material to storage containers should be done under a
fume hood, ideally one that provides for low air move-
ment over powdered material.
Solvent extraction, sonication, filtration
Procedures involved in producing crude toxin extracts
such as vacuum filtration, rotary evaporation, sonication
and lyophilisation should be conducted with regard to
preventing exposure to skin; the usual protective measures
of gloves and lab coat should be worn. Eye splash protec-
tion should be considered for specific procedures, for
example when positive pressure is applied to syringe fil-
ters and solid-phase extraction cartridges; significant force
may be generated such that accidental disconnection of
apparatus under pressure will increase the risk of an explo-
sive spray. Disposal of cyanobacterial biomass remaining
after solvent extraction should be undertaken with regard
to preventing environmental contamination (see section
below: "Environmental risk prevention"). Many water-
soluble cyanotoxins will be extracted with water or meth-
anol; some less polar toxins may be extracted with acetone
or other solvent/s. Additional safety precautions relating
to use of organic solvents should be considered when
these are used for cyanotoxin extraction and purification.
Material safety data sheets (MSDS) for specific solvents
should be consulted for identification and prevention of
additional hazards (e.g. flammability). Use of non-polar
solvents may increase the possibility of dermal absorption
of cyanotoxins; particular care should be taken to protect
the skin from inadvertent exposure.
The final product of crude extraction preparation may,
depending on the particular cyanotoxin, be a concen-
trated and potentially lethal mixture. While accidental
oral exposure in a laboratory setting is a very remote pos-
sibility, vials and containers holding concentrated extracts
should be clearly labelled and identified as toxic materi-
als. Storage of concentrated cyanotoxin extracts, even
though not yet purified, should from this stage be con-
Large-scale laboratory culture of Cylindrospermopsis raciborskii Figure 2
Large-scale laboratory culture of Cylindrospermopsis 
raciborskii. Photo by author WWC.Environmental Health 2009, 8:52 http://www.ehjournal.net/content/8/1/52
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ducted with regard to preventing access by persons with
criminal intent (see below for discussion of biosecurity
provisions).
Preparative and analytical HPLC; HPLC + mass 
spectrometry
Instrumental analytical procedures to further isolate,
purify and quantify cyanotoxins will involve mixing
cyanobacteria extracts with various organic solvents. Sys-
tems should be automated wherever possible to minimise
contact as manual injectors may occasionally obstruct, in
which case explosive sprays may occur. Use of an auto-
mated fraction collector should mitigate inhalation risks;
if fractions are collected manually care should be taken to
ensure that the eluate does not aerosolise. MSDS and
occupational safety requirements for the specific chroma-
tographic solvents should also be consulted.
Lyophilisation, reconstitution and/or storage of 
final product
Quantified, pure cyanotoxin product will be lyophilised
and stored as a solid or reconstituted in a suitable solvent
for storage. Particular care should be taken when handling
glass lyophilisation vessels; pure, dry cyanotoxins have a
low density and are readily dispersible such that acciden-
tal breakage of a vessel in an enclosed space would present
a risk of inhalation exposure. Contamination of labora-
tory floor and bench spaces by lyophilised cyanotoxins
will present hazards to housekeeping staff as well as
research and technical workers.
Decontamination of glassware before routine 
cleaning
In many laboratories, routine collection and cleaning of
reusable glassware is conducted by relatively unskilled
staff. These workers should not be expected to be aware of
the specific risks associated with exposure to highly toxic
materials like cyanobacteria. It should therefore be the
responsibility of laboratory staff working with cyanobac-
teria and/or cyanotoxins to decontaminate used glassware
before sending it for cleaning. Residues remaining on
glassware after preparation of crude extracts or purified
products can in most instances be safely decontaminated
by rinsing with a solvent such as acetone or ethanol, fol-
lowed by a water rinse.
Use of purified cyanotoxins for research 
purposes
Purified cyanotoxins may be used for a wide variety of
research purposes, e.g. determination of physico-chemical
and structural properties, as functional analogues for var-
ious metabolic processes, e.g. anatoxin-a as a nicotinic
agonist [45]; microcystin-LR as a protein phosphatase
inhibitor [46,47], in basic toxicology, toxicokinetics and
toxicodynamics experiments, ecotoxicology studies and
for investigation of pharmacological properties. Some
cyanotoxins are available as standard reference materials
for analytical chemistry work, so laboratories conducting
research and/or routine monitoring work for cyanotoxins
in waters and biota will also use pure cyanotoxins. Some
cyanotoxins (several microcystin congeners, cylindrosper-
mopsin, saxitoxin, neo-saxitoxin, nodularin, anatoxin-a)
are available commercially in microgram quantities.
MSDS are available for these toxins from some suppliers'
websites. Certified reference standards (and MSDS) for
cylindrospermopsin and several saxitoxin analogues are
supplied by the Canadian National Research Council's
Institute for Marine Biosciences, see [48]. Researchers and
scientists working with purified cyanotoxins on various
physico-chemical or in vitro projects should consult the
appropriate MSDS for occupational safety information on
the specific cyanotoxin, cyanotoxin group and/or cyano-
toxin/solvent mixture that most closely matches the par-
ticular cyanotoxin being studied. Researchers working
with uncharacterised cyanotoxins or purified novel cyano-
bacterial compounds should consider the general advice
in this paper and published MSDS, particularly regarding
protection of skin and eyes and avoiding inhalation of dry
product dusts. The remaining discussion on occupational
health and safety matters pertains to cyanotoxin work on
animal models.
Use of pure cyanotoxins for in vivo research
Toxicological and pharmacological research on cyanotox-
ins based on animal models may present some particular
risks both for the researcher and staff working in the ani-
mal research institution. Specific risks will depend on the
exposure route being investigated, the size of the animals
and the concentrations of cyanotoxin being administered.
Most cyanotoxin research to date has been conducted on
small rodents dosed by various parenteral routes. This
reflects one of the main difficulties with in vivo cyanotoxin
research: cyanotoxins in general are difficult or expensive
to procure, so there has been a bias towards the most effi-
cient use of a scarce resource [49]. Dosing of small ani-
mals by the most direct exposure route generates the most
information on toxicological effects from a toxin dose per
unit of body weight basis. There is therefore a relative
dearth of experimental research investigation into the tox-
icology of cyanotoxins in non-rodent and larger animal
models and in all models by oral, inhalational and cuta-
neous/dermal exposure. Such investigations should and
hopefully will be undertaken in future; appropriate occu-
pational safety protocols will need to accompany these
endeavours.
Dosing experimental animals with cyanotoxins by
parenteral exposure routes opens the possibility of acci-
dental injection into research workers. While such an
event should be considered unlikely, the hazard does existEnvironmental Health 2009, 8:52 http://www.ehjournal.net/content/8/1/52
Page 8 of 12
(page number not for citation purposes)
and is most significant in the case of experimental studies
using large animals, when researchers may be handling
doses that are highly toxic or even lethal for humans. Test
animals will then need to be suitably restrained when
syringes and hypodermic needles are used to administer
cyanotoxins.
Inhalational exposure studies will normally be conducted
in an enclosed chamber. Experimental design protocols
should detail measures to eliminate risks to research and
animal facility staff from accidental and incidental expo-
sure to aerosolised cyanotoxins.
Cutaneous or dermal exposure studies are likely to use
carrier vehicles other than water, i.e. relatively less polar
solvents such as ethanol, methanol or acetone that will
allow the chemical of interest to partition across cutane-
ous and epidermal tissues. Use of less polar vehicles will
thus place researchers at greater risk of dermal exposure to
water-soluble cyanotoxins that would otherwise not be
expected to penetrate the skin to any significant extent.
Cyanotoxins dissolved in the polar aprotic solvent dime-
thyl sulfoxide (DMSO) will present a particular dermal
exposure hazard. Lethal intoxications by the dermal expo-
sure route have been reported for both microcystin-LR
and saxitoxin in DMSO administered to guinea pigs [50].
Experimental oral dosing of cyanotoxins will usually be
accomplished by gavaging aqueous solutions or by add-
ing known quantities of cyanotoxin to drinking water sup-
plies. Feeding experiments to investigate trophic transfer
of cyanotoxins or dietary transfer efficiency of contami-
nating cyanotoxins (e.g. from cyanobacteria-based nutri-
tional supplements containing contaminant toxigenic
cyanobacteria, or market garden produce spray irrigated
with cyanotoxin-contaminated water) are conceivable.
Oral exposure studies should, at the design stage, consider
the potential for cyanotoxins in food or water supplies to
be dispersed by experimental animals, and the attendant
occupational safety risks for research and animal facility
staff. Dry feed (e.g. containing cyanotoxin-contaminated
fish meal) may be subject to dust formation by active ani-
mals. From an occupational health perspective, cyanoto-
xin feeding studies should, if possible, be conducted using
moist feed. Contingency protocols for cleaning and dis-
posal of spilled food and water should be applied.
Main excretion routes for the various cyanotoxins are via
urine and faeces; proportional elimination by each route
varies according to the specific cyanotoxin. The urinary
system is the principal excretion pathway for cylindros-
permopsin [51], whereas the microcystins (at least those
variants that have been studied in this context) are mainly
eliminated through the bile and then into faeces [13]. Sax-
itoxins are eliminated in urine and faeces [52,53].
Researchers and animal house staff collecting or disposing
of urine from cyanotoxin-dosed animals should apply
procedures to minimise aerosol formation. Latex or nitrile
gloves should be worn at all times when handling excreta;
faeces and carcases should be disposed of by incineration.
The general hazards outlined in the above discussion, and
recommended management practices, are summarised in
Table 1.
Other occupational safety matters relating to 
cyanobacteria and cyanotoxins
￿ Radiolabelled toxin: Some researchers may grow
toxigenic cyanobacteria in media with an added 14C
source in order to produce labelled cyanotoxin for tox-
icokinetics studies or other research endeavours.
Workers producing and using radiolabelled cyanotox-
ins will need to prepare occupational safety protocols
that consider safe use and disposal of such toxins.
Such protocols should reflect the risks associated with
exposure to both the cyanotoxin and the radioisotope.
Animal house staff will need to be aware of the poten-
tial for labelled toxin excreted in the urine of experi-
mental animals to be aerosolised.
￿ Use of toxic cyanobacteria (i.e. not purified tox-
ins): Workers from varying research backgrounds (e.g.
genetics, ecology) may work directly with toxigenic
cyanobacteria rather than purified cyanotoxins. Toxi-
cology researchers may also work directly with crude
or partially purified extracts of toxic cyanobacteria in
order to overcome difficulties relating to availability of
purified toxins. This has advantages related to quantity
of supply, especially if the amounts of toxin required
are high. An example of this is an oral toxicity trial car-
ried out in pigs with Microcystis bloom material, which
involved collection and processing of several thou-
sand litres of cyanobacterial scum [54]. Occupational
health risks from this exercise included skin contact
and inhalation risk in scum collection, mixing, sub-
sampling and supply to the animals. In the near future
it is likely that a major cyanobacterial processing effort
will be required in order to supply the quantities of
toxin needed for extended oral toxicity trials in rats or
dogs, which will form an essential part of carcino-
genicity risk assessment. And a recent recommenda-
tion has been made for clonal cultures of
cyanobacteria that have been characterised with
respect to toxin production to be made available to
toxicology researchers internationally to allow for
inter-laboratory comparison of findings [49]. Contact
with cyanobacterial blooms or extracts may involve
risks from components other than the toxin under
investigation, due to the wide range of bioactive mate-
rials in cyanobacteria [55].Environmental Health 2009, 8:52 http://www.ehjournal.net/content/8/1/52
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The discussion in this paper on the various health risks
and safety strategies for scientific and technical staff work-
ing on purified cyanotoxins may be applied to tasks
involving handling of toxigenic cyanobacteria and various
extracts from same. However, further considerations relat-
ing to disposal of potentially viable cyanobacterial cells
should apply, and are discussed in the following section.
Environmental risk prevention
Invasive microalgal incursions causing significant eco-
nomic and ecological impacts have been reported from
both marine and freshwater environments. Ballast water
escapes of toxic marine dinoflagellates causing outbreaks
of human saxitoxin poisoning in new geographic regions
have been reported [56]. Invasions of the freshwater dia-
tom Didymosphenia geminata in New Zealand rivers have
caused widespread ecological damage, adverse affects on
recreational fisheries and fouling of water off-take struc-
tures [57]. It is important that researchers working with
living or viable cyanobacteria do not contribute to the
problem of feral microalgae when disposing of spent cul-
ture material or harvested bloom material. Inter- and
intra-national movement of live cyanobacteria occurs
across several and varied research endeavours, e.g. toxicol-
ogy, ecology, genetics, pharmacology and natural prod-
ucts discovery. Indeed, for cyanotoxin researchers a recent
recommendation has been made to expand inter-labora-
tory availability of clonal cyanobacterial cultures [49].
Customs and quarantine clearances covering importation
of live cyanobacteria should incorporate protocols for safe
disposal of solid and liquid waste containing live or
potentially viable cells. However, transport and use of live
cyanobacteria within national borders will not be subject
to any regulatory oversight, so the onus will be on individ-
ual researchers and institutions to take responsibility for
the safe environmental disposal of native cyanobacteria.
Translocation of "native" biota from outside its natural
range can result in catastrophic ecological consequences,
in much the same way as the establishment of interconti-
nental feral pests. Australia, for example, has some partic-
ularly troubling experiences with the inter-regional
invasion of native plants [58]. The invasive potential of
cyanobacteria is essentially unknown, but a precautionary
approach by research workers in this regard is imperative.
Cyanobacteria can produce a wide array of biologically
active metabolites, some of which are toxic to humans
and animals. Allelopathic properties may be a particular
Table 1: Summary of specific hazards encountered when processing toxic cyanobacteria to produce cyanotoxins, and recommended 
control measures
Procedure Hazard Control measure
Bulk harvesting - wet biomass Oral exposure Avoid accidental immersion
Cutaneous and mucous membrane exposure PPE: waterproof boots, gloves, waders; avoid 
splash generation
Inhalation exposure Work in calm water condition
Bulk harvesting - dry biomass Cutaneous and mucous membrane exposure PPE: gloves, overalls
Inhalation exposure Consider wetting prior to harvest, otherwise 
protective respirator mask
Laboratory culture of toxic cyanobacteria Cutaneous and mucous membrane exposure PPE: gloves, lab coat, eye splash protection for 
specific procedures. Contingency procedures to 
manage accidental spillage
Inhalation exposure Discontinue aeration for 5 minutes before 
opening culture vessels
Concentration, lyophilisation, powdering Cutaneous and mucous membrane exposure PPE: gloves, lab coat, eye splash protection
Inhalational exposure Low-flow fume cupboard
PPE: face mask
Solvent extraction, sonication, filtration, 
chromatography,
Cutaneous and mucous membrane exposure PPE: gloves, lab coat, eye splash protection for 
specific procedures
Inhalational exposure PPE: face mask for procedures affording risk of 
spray generation
Lyophilisation of pure product Cutaneous exposure PPE: gloves, lab coat
Inhalational exposure Care to avoid vessel breakage
PPE: face mask
Toxicity studies using in vivo models Parenteral exposure Care when handling hypodermic needles, 
restraint of animals for dosing
Cutaneous exposure PPE: gloves, lab coat
Inhalational exposure Procedures to minimise or eliminate aerosol 
formation when disposing of urine. Experimental 
design features to avoid dry dust dispersal in 
feeding studies
PPE: face mask if aerosols likelyEnvironmental Health 2009, 8:52 http://www.ehjournal.net/content/8/1/52
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ecological hazard, should accidental escapes become suc-
cessful bioinvasions [59].
Solid waste cyanobacteria should be incinerated. Liquid
wastes may be autoclaved at 121°C for 15-20 minutes in
the case of small volumes; up to 60 minutes for volumes
up to 10 L. If a suitably sized autoclave is not available or
large volumes (>10 L) of spent growth medium are to be
disposed of, a chemical oxidant should be used to ensure
that all cyanobacterial cells are rendered non-viable.
Chlorine bleach is widely used for large liquid volumes
which require sterilisation as it is effective in rendering
cells non-viable but may not kill all specialised cells such
as cysts (in the case of eukaryotic microalgae) [60]. Apply-
ing this understanding to cyanobacteria, it may be appro-
priate to assume that bleach may not destroy all akinetes,
though it seems that the specific topic of cyanobacterial
akinete eradication has not been well researched. Normal
application rates are 1-5 mL of commercial bleach per litre
of liquid, with several hours reaction time required (this
can vary depending on the concentration of organic mat-
ter and exposure to sunlight during treatment). Shorter
reaction times can be achieved with higher concentrations
of bleach. Neutralisation of the treated solution with a
reducing agent (1 mL of 25%w/v sodium thiosulfate solu-
tion per 4 mL of bleach) is required before disposal [60].
Acidified hypochlorite has a stronger antimicrobial action
than stable bleach due to an increased concentration of
dissociated HClO. Addition of acetic acid to hypochlorite
solutions to pH 5.0 provides a highly effective bactericide
[61], though additional occupational safety considera-
tions will need to be observed regarding the potential for
liberation of chlorine gas from hypochlorous acid. Acidi-
fied hypochlorite can be added to liquid waste prior to
disposal to make a 5-10% v/v concentration; contact time
with hypochlorite should be at least 30 minutes, and chlo-
rinated wastes should be further diluted before disposing
into domestic wastewater systems. Copious volumes of
liquid waste that might conceivably be generated by (for
example) a large animal feeding study may need to be
handled by a professional liquid waste disposal agency.
Culture vessels and any accessory laboratory equipment
that has had contact with viable cyanobacteria should be
decontaminated (soaked, ideally) with hypochlorite solu-
tion before being rinsed and cleaned. Autoclavable labo-
ratory equipment should be heat sterilised. Field
sampling equipment should likewise be decontaminated
between use at different sites and prior to storage.
Biosecurity and bioterrorism precautions
As many cyanobacterial products are highly potent toxins,
a number of these compounds have come to the attention
of national security agencies in some countries because of
their potential to be used as chemical weapons. Saxitoxin
is scheduled as a toxic chemical under the Chemical
Weapons Convention; saxitoxin and microcystin are on
the Australia Group list of biological agents for export
control [62,63]. Research facilities that make, acquire and
use cyanotoxins may be subject to regulatory oversight
regarding production, storage and transport of these
materials [64]. Researchers who are not currently the
focus of such scrutiny might anticipate some changes in
this regard, so it may be prudent to establish and maintain
pre-emptive protocols to document the quantities of vari-
ous cyanotoxins that are purchased, produced and used,
and to establish secure storage and laboratory facilities.
Restricted access may be a requirement of police and/or
security agencies when pure cyanotoxins are produced in
multimilligram quantities. Safeguards are necessary to
prevent theft and diversion for nefarious purposes,
though some workers have noted that recent regulatory
concerns have impeded legitimate research activities, and
have called for provisions for safe transport and use in
secure laboratories [48].
Conclusion
Exposure to cyanotoxins via oral, inhalational or cutane-
ous exposure routes during harvesting or production,
extraction and purification will depend on the specific
task being conducted. Harmful consequences of such
exposure can be expected to vary according to the specific
cyanotoxin encountered, as well as the usual dose-related
considerations. Common to all occupational health and
safety strategies, the efficacy of protection measures will
depend on both the appropriate choice of intervention
and its acceptance by laboratory staff. These aims may be
achieved through education programs to identify poten-
tial hazards from particular task-related exposure path-
ways, discussing risks and attendant amelioration
measures, and documenting revisions to such programs.
Identification of hazards to ancillary laboratory workers
and measures to prevent the introduction of viable cyano-
bacterial cells to the external aquatic environment should
be essential considerations.
Personal protection should be maintained at all times to
minimise human exposure risk during collection of
bloom material, mass culture production, toxin extrac-
tion, purification and quantitation, in vivo applications
and live culture disposal. General laboratory personal
protection encompasses the wearing of laboratory coats,
appropriate gloves (eg: nitrile gloves for solvent expo-
sure), safety glasses (splash protection), face masks (when
potentially exposed to sprays, powders and dried toxic
material) and handling of toxic material in fume hoods.
Access to chemical alert databases and material safety data
sheets is mandatory and the creation of standard operat-Environmental Health 2009, 8:52 http://www.ehjournal.net/content/8/1/52
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ing procedures for general occupational safety including
procedures for spillages is strongly recommended.
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